"Streptococcus pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Descriptor ID |
D013296
|
MeSH Number(s) |
B03.353.750.737.872.550 B03.510.400.800.872.550 B03.510.550.737.872.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus pneumoniae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus pneumoniae".
This graph shows the total number of publications written about "Streptococcus pneumoniae" by people in this website by year, and whether "Streptococcus pneumoniae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1999 | 2 | 2 | 4 |
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 3 | 2 | 5 |
2003 | 1 | 2 | 3 |
2004 | 2 | 3 | 5 |
2005 | 2 | 0 | 2 |
2006 | 4 | 1 | 5 |
2007 | 5 | 2 | 7 |
2008 | 4 | 1 | 5 |
2009 | 2 | 0 | 2 |
2010 | 2 | 0 | 2 |
2011 | 9 | 0 | 9 |
2012 | 3 | 3 | 6 |
2013 | 3 | 3 | 6 |
2014 | 8 | 5 | 13 |
2015 | 5 | 2 | 7 |
2016 | 7 | 3 | 10 |
2017 | 9 | 6 | 15 |
2018 | 4 | 1 | 5 |
2019 | 8 | 2 | 10 |
2020 | 9 | 3 | 12 |
2021 | 3 | 11 | 14 |
2022 | 3 | 3 | 6 |
2023 | 4 | 7 | 11 |
2024 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus pneumoniae" by people in Profiles.
-
Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
-
Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health Technol Assess. 2024 Jul; 28(34):1-109.
-
Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: a case-control study. BMC Infect Dis. 2024 Jun 26; 24(1):637.
-
Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study. Lancet Child Adolesc Health. 2024 Mar; 8(3):201-213.
-
Nanofluidic qPCR unable to detect and serotype Streptococcus pneumoniae in urine samples of hospitalized South African patients with community-acquired pneumonia. Sci Rep. 2023 12 04; 13(1):21332.
-
Bacterial nasopharyngeal colonisation in children in South Africa before and during the COVID-19 pandemic: an observational study. Lancet Microbe. 2024 01; 5(1):e34-e42.
-
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health. 2023 09; 5(9):e582-e593.
-
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
-
Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. Int J Infect Dis. 2023 Sep; 134:45-52.